M. Schneider

发表

Results in children of acute lymphoid leukaemia protocol ICIG-ALL 9 consisting of chemotherapy for only nine months followed by active immunotherapy

F. Vassal, J. Misset, C. Jasmin, 1977, Cancer Immunology, Immunotherapy.

Preliminary results of three protocols for the treatment of acute lymphoid leukaemia of children: distinction of two groups of patients according to predictable prognosis.

J. Misset, C. Jasmin, G. Mathé, 1978, Medical and pediatric oncology.

Active immunotherapy for acute lymphoblastic leukaemia.

G. Mathé, L. Schwarzenberg, M. Hayat, 1969, Lancet.

1975 current results of the first 100 cytologically typed acute lymphoid leukemia submitted to BCG active immunotherapy

F. Vassal, J. Misset, C. Jasmin, 1976, Cancer Immunology, Immunotherapy.

Attempts at Immunotherapy of 100 Acute Lymphoid Leukemia Patients: Some Factors Influencing Results

F. Vassal, C. Jasmin, G. Mathé, 1974 .

Attempts at stimulation of immune response in acute lymphod leukaemia.

G. Mathé, P. Pouillart, L. Schwarzenberg, 1972, Proceedings of the Royal Society of Medicine.

Active Immunotherapy by B.C.G.

G. Mathé, L. Schwarzenberg, M. Schneider, 1971 .

Methods and Strategy for the Treatment 1 of Acute Lymphoblastic Leukemia

F. Vassal, G. Mathé, L. Schwarzenberg, 1970 .

Immunogenetic and immunological problems of allogeneic haemopoietic radio-chimaeras in man.

M. Tubiana, G. Mathé, L. Schwarzenberg, 2009, Scandinavian journal of haematology.

EXPERIMENTAL THERAPEUTIC TRIALS OF LEUKEMIA AND HEMATOSARCOMAS: TECHNOLOGIC AND PHILOSOPHIC ASPECTS

G. Mathé, L. Schwarzenberg, A. Cattan, 1969, Annals of the New York Academy of Sciences.

METHYL-HYDRAZINE IN TREATMENT OF HODGKIN'S DISEASE AND VARIOUS FORMS OF HAEMATOSARCOMA AND LEUKAEMIA.

G. Mathé, L. Schwarzenberg, A. Cattan, 1963, Lancet.

Study of factors determining the usefulness and complications of leukocyte transfusions.

G. Mathé, L. Schwarzenberg, A. Cattan, 1967, The American journal of medicine.

SUCCESSFUL ALLOGENIC BONE MARROW TRANSPLANTATION IN MAN: CHIMERISM, INDUCED SPECIFIC TOLERANCE AND POSSIBLE ANTI-LEUKEMIC EFFECTS.

M. Tubiana, J. Binet, G. Mathé, 1965, Blood.

Results of a randomized trial of prophylactic chemotherapy in T3-T4 breast cancer patients previously treated by radiotherapy.

M. Namer, G. Mathé, P. Chollet, 1978, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[TRIAL TREATMENT OF HODGKIN'S DISEASE AND VARIOUS HEMATOSARCOMAS AND LEUKEMIAS WITH A METHYLHYDRAZINE. STUDY BASED ON 100 PATIENTS].

G. Mathé, L. Schwarzenberg, A. Cattan, 1964, La Presse medicale.

Follow-up of the first (1962) pilot study of active immunotherapy of acute lymphoid leukaemia: a critical discussion.

G. Mathé, L. Schwarzenberg, M. Hayat, 1977, Biomedicine / [publiee pour l'A.A.I.C.I.G.].

[TRIAL TREATMENT BY EPSILON-AMINOCAPROIC ACID OF PATIENTS WITH HEMORRHAGIC SYNDROMES, ESPECIALLY SYNDROMES RELATED TO A THROMBOCYTOPENIA].

G. Mathé, L. Schwarzenberg, A. Cattan, 1963, La Presse medicale.

Two epipodophyllotoxin derivatives, VM 26 and VP 16213, in the treatment of leukemias, hematosarcomas, and lymphomas

J. Misset, C. Jasmin, G. Mathé, 1974, Cancer.

[TRIAL TREATMENT OF CHRONIC MYELOID LEUKEMIA WITH DIBROMOMANNITOL].

G. Mathé, L. Schwarzenberg, A. Cattan, 1964, Nouvelle revue francaise d'hematologie.

Haematopoietic Chimera in Man After Allogenic (Homologous) Bone-marrow Transplantation

G. Mathé, L. Schwarzenberg, A. Cattan, 1963, British medical journal.

Bone Marrow Graft in Man after Conditioning by Antilymphocytic Serum*

C. Jasmin, G. Mathé, L. Schwarzenberg, 1970, British medical journal.

Adoptive immunotherapy of acute leukemia: experimental and clinical results.

G. Mathé, L. Schwarzenberg, A. Cattan, 1965, Cancer research.

Bone marrow graft in man after conditioning by antilymphocytic serum.

C. Jasmin, G. Mathé, L. Schwarzenberg, 1971, Transplantation proceedings.

[Allogenic bone marrow graft in man proved by 6 antigenic tracers after conditioning of the receiver and donor by antilymphocyte serum].

C. Jasmin, G. Mathé, L. Schwarzenberg, 1968, Revue francaise d'etudes cliniques et biologiques.

Subdivision of classical varieties of acute leukemia. Correlation with prognosis and cure expectancy.

C. Jasmin, G. Mathé, P. Pouillart, 1971, Revue europeenne d'etudes cliniques et biologiques. European journal of clinical and biological research.

Acute lymphoblastic leukaemia treated with a combination of prednisone, vincristine, and rubidomycin. Value of pathogen-free rooms.

C. Jasmin, G. Mathé, L. Schwarzenberg, 1967, Lancet.

Bone marrow transplantation in man.

G. Mathé, L. Schwarzenberg, A. Cattan, 1969, Transplantation proceedings.

Attempted adoptive immunotherapy of acute leukaemia by leucocyte transfusions.

G. Mathé, L. Schwarzenberg, A. Cattan, 1966, Lancet.

[A new combination of methotrexate and folinic acid for cancer treatment (acute leukemia and solid tumors)].

C. Jasmin, G. Mathé, L. Schwarzenberg, 1969, La Presse medicale.

White blood cell transfusions.

G. Mathé, L. Schwarzenberg, J. de Grouchy, 1965, Israel journal of medical sciences.

[Attempt of treatment of acute lymphoblastic leukemia by L-asparaginase].

C. Jasmin, G. Mathé, L. Schwarzenberg, 1969, La Presse medicale.

Hydroxyurea, Leucopheresis, and Splenectomy in Chronic Myeloid Leukaemia at the Problastic Phase

C. Jasmin, G. Mathé, P. Pouillart, 1973, British medical journal.

Experimental Basis and Clinical Results of Leukemia Adoptive Immunotherapy

G. Mathé, P. Pouillart, L. Schwarzenberg, 1970 .

The immunological approach to the treatment of human cancer.

G. Mathé, L. Schwarzenberg, A. Cattan, 1967, European journal of cancer.

Extensive Histological and Cytological Survey of Patients with Acute Leukaemia in “Complete Remission”*

G. Mathé, L. Schwarzenberg, A. Cattan, 1966, British medical journal.

The role of immunology in the treatment of leukemias and hematosarcomas.

G. Mathé, L. Schwarzenberg, A. Cattan, 1967, Cancer research.

[Intensive anticancer chemotherapy. Transfusion of autologous bone marrow. Rooms exempt of pathogenic germs].

G. Mathé, L. Schwarzenberg, A. Cattan, 1966, La Presse medicale.

["Hematologic resuscitation". I. Correction of severe disorders of the erythrocytic line and of coagulation disorders].

G. Mathé, L. Schwarzenberg, A. Cattan, 1966, La Presse medicale.

Eosinophilic granuloma of femur and lungs: a case report.

J. H. Childers, M. Schneider, J. W. Middleton, 1955, Annals of internal medicine.

Adriamycin in the Treatment of Acute Leukemias

F. Vassal, C. Jasmin, G. Mathé, 1972 .

[Trial treatment, by cyclophosphamide. of acute lymphoblastic leukemia and lymphoblastosarcoma].

G. Mathé, L. Schwarzenberg, A. Cattan, 1963, Nouvelle revue francaise d'hematologie.

CHAPTER 35 – IMMUNOTHERAPY VERSUS CHEMOIMMUNOTHERAPY AS ADJUVANT TREATMENT OF MALIGNANT MELANOMA

G. Mathé, B. Mével, B. Serrou, 1985 .

[Allogenic bone marrow graft after conditioning with only antilymphocytic serum in states of bone marrow aplasias].

C. Jasmin, G. Mathé, L. Schwarzenberg, 1970, La Presse medicale.

BCG in cancer immunotherapy: experimental and clinical trials of its use in treatment of leukemia minimal and or residual disease.

C. Jasmin, G. Mathé, P. Pouillart, 1973, National Cancer Institute monograph.

Preliminary result of a new protocol for the active immunotherapy of acute lymphoblastic leukaemia: inhibition of the immunotherapeutic effect by Vincristine or Adamantadine.

C. Jasmin, G. Mathé, P. Pouillart, 1971, Revue europeenne d'etudes cliniques et biologiques. European journal of clinical and biological research.

Bone marrow transplantation after antilymphocyte globulin conditioning--split lymphocyte chimerism.

C. Jasmin, G. Mathé, D. Belpomme, 1972, Transplantation proceedings.

[The immune response in Hodgkin's disease].

G. Mathé, L. Schwarzenberg, M. Hayat, 1970, La Presse medicale.

The time factor in cancer chemotherapy.

G. Mathé, L. Schwarzenberg, M. Schneider, 1970, European journal of cancer.

Follow-up results from a randomized trial for T3 and T4 breast cancer patients: previous BCG immunotherapy improves response to chemotherapy in the relapse patient.

G. Mathé, P. Chollet, N. Namer, 1982, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[Acute leukemia syndromes (ALS) appearing during the evolution of hematosarcomas and chronic leukemias (clinical analysis)].

M. Tubiana, G. Mathé, F. Calman, 1967, Nouvelle revue francaise d'hematologie.

Blastic Leukemia Complicating Reticulo-Sarcoma and Lympho-Sarcoma

G. Mathé, L. Schwarzenberg, A. Cattan, 1970 .

Preliminary Data on Acute Leukemia Treatment with ICRF 159

F. Vassal, C. Jasmin, G. Mathé, 1970 .

[HEMATOPOIETIC CHIMERISM IN MAN AFTER GRAFT OF ALLOGENIC BONE MARROW. CONTROL OF THE SECONDARY SYNDROME. SPECIFIC TOLERANCE RELATED TO THE CHIMERISM].

G. Mathé, L. Schwarzenberg, A. Cattan, 1963, Comptes rendus hebdomadaires des seances de l'Academie des sciences.

Treatment of Blastic Crisis in Chronic Myelocytic Leukemia

G. Mathé, L. Schwarzenberg, A. Cattan, 1970 .

Preliminary results of an immunotherapy trial on terminal leukaemic lymphosarcoma.

J. Misset, G. Mathé, D. Belpomme, 1975, Biomedicine / [publiee pour l'A.A.I.C.I.G.].

Pathogen-free isolation unit — Three years' experience*

C. Jasmin, G. Mathé, L. Schwarzenberg, 1969, British medical journal.

[TRIAL TREATMENT OF VARIOUS "PROTEUS" INFECTIONS WITH 2,4-DIAMINO-5-(3,4,5-TRIMETHOXYBENZYL) PYRIMIDINE, OR (TRIM'ETHOPRIME)].

G. Mathé, L. Schwarzenberg, A. Cattan, 1965, La Presse medicale.

[Chemotherapy of L1210 leukemia: comparison of 7 drugs given either continuously for 20 days, or in a single massive dose, early or late].

G. Mathé, L. Schwarzenberg, M. Hayat, 1968, Revue francaise d'etudes cliniques et biologiques.

[Trial of adriamycin in the treatment of acute leukemia].

C. Jasmin, G. Mathé, L. Schwarzenberg, 1970, La Presse medicale.

[Hematologic resuscitation. II. Correction of severe leukocyte and immune globulin disorders. The bone marrow graft].

G. Mathé, L. Schwarzenberg, A. Cattan, 1966, La Presse medicale.

Induced Specific Tolerance and Possible Anti-Leukemic Effects Successful Allogenic Bone Marrow Transplantation in Man: Chimerism,

J. Binet, L. Schwarzenberg, A. Cattan, 2011 .

Five Years Experience of the Clinical Use of a Pathogen-Free Isolation Unit

F. Vassal, C. Jasmin, G. Mathé, 1970 .

Methoxy-9-ellipticine lactate. 3. Clinical screening: its action in acute myeloblastic leukaemia.

C. Jasmin, G. Mathé, L. Schwarzenberg, 1970, Revue europeenne d'etudes cliniques et biologiques. European journal of clinical and biological research.